News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,002 Results
Type
Article (8030)
Company Profile (140)
Press Release (477831)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166834)
Career Advice (305)
Deals (25748)
Drug Delivery (7)
Drug Development (52881)
Employer Resources (14)
FDA (9767)
Job Trends (8576)
News (238310)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33184)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (277)
Approvals (10405)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6958)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3720)
Cardiovascular disease (225)
Career advice (246)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47998)
Collaboration (1271)
Commercialization (3)
Compensation (1519)
Complete response letters (34)
COVID-19 (758)
CRISPR (64)
C-suite (791)
Cystic fibrosis (86)
Data (5808)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4223)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73764)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88060)
Executive appointments (711)
FDA (12460)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (937)
Gene editing (126)
Generative AI (9)
Gene therapy (330)
GLP-1 (295)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9369)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (948)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1972)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5197)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (521)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (555)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8676)
Medtech (8831)
Mergers & acquisitions (14410)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (105)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1851)
NextGen: Class of 2026 (3150)
Non-profit (844)
Obesity (227)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Patient selection (1)
Peanut (31)
People (41361)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15507)
Phase 2 (21428)
Phase 3 (14451)
Pipeline (7606)
Policy (18)
Postmarket research (1570)
Preclinical (6550)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (583)
Real estate (3028)
Recruiting (6)
Regulatory (14913)
Reports (23)
Research institute (586)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Supply chain (51)
Vaccines (333)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Today (76)
Last 7 days (381)
Last 30 days (1461)
Last 365 days (19049)
2026 (13341)
2025 (19257)
2024 (22999)
2023 (26550)
2022 (34626)
2021 (37203)
2020 (33498)
2019 (23272)
2018 (17500)
2017 (18770)
2016 (17927)
2015 (24269)
2014 (21684)
2013 (18142)
2012 (20224)
2011 (20444)
2010 (20338)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17949)
Australia (2113)
California (12275)
Canada (3218)
China (538)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24805)
Florida (1839)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (718)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1223)
Massachusetts (8055)
Michigan (313)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2677)
New Mexico (12)
New York (2877)
North Carolina (1311)
North Dakota (4)
Northern California (6168)
Ohio (289)
Oklahoma (14)
Oregon (16)
Pennsylvania (2291)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5108)
Tennessee (122)
Texas (1989)
United States (39782)
Utah (369)
Vermont (1)
Virginia (156)
Washington D.C. (38)
Washington State (954)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,002 Results for "biomerieux inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bioMérieux to Showcase Company’s Latest in Diagnostic Innovations at ADLM 2026
July 14, 2026
·
3 min read
Press Releases
bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026
August 9, 2026
·
3 min read
Press Releases
bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
April 10, 2026
·
3 min read
Press Releases
Minaris Expands Rapid Mycoplasma Detection Services with bioMérieux’s BIOFIRE® Platform to Reduce Turnaround Time for Release and In-Process Testing
May 27, 2026
·
4 min read
Press Releases
bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM
August 6, 2025
·
4 min read
Press Releases
OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence
August 26, 2025
·
5 min read
Press Releases
4th Edition of bioMérieux Canada Symposium: Over 300 Canadian Health Experts Unite in Toronto to Tackle the Growing Threat of Antimicrobial Resistance
November 21, 2025
·
3 min read
BioMidwest
USDA Awards bioMérieux GENE-UP® CAMPLYLOBACTER as Method of Choice for Campylobacter Detection in USDA Food Safety and Inspection Service Laboratories
bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the incorporation of the company’s GENE-UP® CAMPYLOBACTER assay into the methodology used by the USDA-FSIS Field Service Laboratories.
June 11, 2024
·
3 min read
Deals
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux announces the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.
January 15, 2024
·
3 min read
BioMidwest
bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens
bioMérieux, a world leader in in vitro diagnostics for 60 years, has entered into a strategic research collaboration with the US Food and Drug Administration, Center for Food Safety and Applied Nutrition, Offices of Applied Research and Safety Assessment and Regulatory Science to develop tools to combat food-borne pathogens.
February 28, 2024
·
3 min read
1 of 48,601
Next
